GPR89A 抗体 (3rd Cytoplasmic Domain)
Quick Overview for GPR89A 抗体 (3rd Cytoplasmic Domain) (ABIN1735192)
抗原
See all GPR89A 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- 3rd Cytoplasmic Domain
- 
                                            特异性
- Reacts with human GPR89A
- 
                                            交叉反应
- 大鼠
- 
                                            交叉反应 (详细)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins. Cross reacts with rat protein.
- 
                                            纯化方法
- Antigen affinity purified
- 
                                            免疫原
- Synthetic 19 amino acid peptide from 3rd cytoplasmic domain of human GPR89A. Percent identity with other species by BLAST analysis: Human (100%), Gibbon (95%), Monkey (95%), Dog (95%), Bovine (95%), Horse (95%), Pig (95%), Opossum (95%), Marmoset (89%)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Working dilution: IHC-P (34 μg/mL 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1 mg/mL
- 
                                            缓冲液
- PBS, Sodium azide 0.1 %
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C/-80 °C
- 
                                            储存方法
- Long term: -70°C, Short term: +4°C
 
- 
                                            
- 
    - GPR89A (G Protein-Coupled Receptor 89A (GPR89A))
- 
                                            别名
- GPR89A
 抗原
- 
                    
 
                                     
                                     
                                    